---
title: "YABAO PHARM.CORP disclosed the progress of its share repurchase, having repurchased a total of 6 million shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/260391193.md"
description: "YABAO PHARM.CORP disclosed the progress of its share repurchase. Since the shareholders' meeting approved the repurchase proposal on May 16, 2025, the company has repurchased a total of 6 million shares, accounting for 0.86% of the total share capital. The repurchase period is from May 16, 2025, to November 14, 2025, with an expected repurchase amount between 50 million and 100 million yuan, mainly used to reduce registered capital. The highest transaction price for the repurchase was 6.65 yuan/share, the lowest was 6.30 yuan/share, and the total payment amount was 38,878,040 yuan"
datetime: "2025-10-09T07:53:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/260391193.md)
  - [en](https://longbridge.com/en/news/260391193.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/260391193.md)
---

# YABAO PHARM.CORP disclosed the progress of its share repurchase, having repurchased a total of 6 million shares

YABAO PHARM.CORP announced the progress of its share repurchase through centralized bidding. The company's shareholders' meeting approved the repurchase proposal on May 16, 2025, with the repurchase period from May 16, 2025, to November 14, 2025, and an expected repurchase amount of 50 million to 100 million yuan, aimed at reducing registered capital. As of September 30, a total of 6 million shares have been repurchased, accounting for 0.86% of the total share capital, with a highest transaction price of 6.65 yuan/share and a lowest of 6.30 yuan/share, totaling a payment amount of 38,878,040 yuan

### Related Stocks

- [600351.CN](https://longbridge.com/en/quote/600351.CN.md)

## Related News & Research

- [ZAWYA: UAE developers accelerate shift to recurring income amid market uncertainty](https://longbridge.com/en/news/287012545.md)
- [Europe-China spacecraft launches to study Earth's 'invisible armour'](https://longbridge.com/en/news/286881963.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [HSA warns public against consuming herbal remedy containing potent steroid](https://longbridge.com/en/news/287022845.md)
- [ZAWYA: Emirates Islamic and FC Barcelona unite to launch exclusive co-branded card](https://longbridge.com/en/news/287034377.md)